181 related articles for article (PubMed ID: 32440961)
21. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
22. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
[TBL] [Abstract][Full Text] [Related]
23. Chemoembolization for intermediate HCC: is there proof of survival benefit?
Forner A; Llovet JM; Bruix J
J Hepatol; 2012 Apr; 56(4):984-6. PubMed ID: 22008737
[TBL] [Abstract][Full Text] [Related]
24. Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
Yan J; Li T; Deng M; Fan H
Front Oncol; 2022; 12():927123. PubMed ID: 35785181
[TBL] [Abstract][Full Text] [Related]
25. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
Wang L; Ke Q; Lin N; Zeng Y; Liu J
Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401
[No Abstract] [Full Text] [Related]
26. Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis.
Zhang FQ; Li L; Huang PC; Fu YF; Xu QS
Minim Invasive Ther Allied Technol; 2022 Jun; 31(5):676-683. PubMed ID: 34634985
[TBL] [Abstract][Full Text] [Related]
27. Repeated Radiofrequency Ablation Combined With Ablated Lesion Elimination and Transarterial Chemoembolization Improves the Outcome of Solitary Huge Hepatocellular Carcinomas 10 m or Larger.
Ke S; Gao J; Kong J; Ding XM; Niu HG; Xin ZH; Ning CM; Guo SG; Li XL; Zhang L; Dong YH; Sun WB
Medicine (Baltimore); 2016 Apr; 95(16):e3393. PubMed ID: 27100425
[TBL] [Abstract][Full Text] [Related]
28. TACE versus TAE as therapy for hepatocellular carcinoma.
Pleguezuelo M; Marelli L; Misseri M; Germani G; Calvaruso V; Xiruochakis E; Manousou P; Burroughs AK
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1623-41. PubMed ID: 18925854
[TBL] [Abstract][Full Text] [Related]
29. Emergency versus delayed hepatectomy following transarterial embolization in spontaneously ruptured hepatocellular carcinoma survivors: a systematic review and meta-analysis.
Zhang W; Huang Z; Che X
World J Surg Oncol; 2022 Nov; 20(1):365. PubMed ID: 36397082
[TBL] [Abstract][Full Text] [Related]
30. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma.
Kim JY; Lee JS; Oh DH; Yim YH; Lee HK
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):640-5. PubMed ID: 22395224
[TBL] [Abstract][Full Text] [Related]
31. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ
BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.
Hung AK; Guy J
World J Gastroenterol; 2015 Nov; 21(42):12197-210. PubMed ID: 26576104
[TBL] [Abstract][Full Text] [Related]
33. Comparison of transarterial bland and chemoembolization for neuroendocrine tumours: a systematic review and meta-analysis.
Tai E; Kennedy S; Farrell A; Jaberi A; Kachura J; Beecroft R
Curr Oncol; 2020 Dec; 27(6):e537-e546. PubMed ID: 33380868
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
Ludwig JM; Zhang D; Xing M; Kim HS
Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
Liao M; Zhu Z; Wang H; Huang J
Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic Left Hepatectomy for Ruptured Hepatocellular Carcinoma Controlled After Transcatheter Arterial Embolization: Case Report and Review of the Literature.
Yoshiya S; Iwaki K; Sakai A; Fujita S; Kawasaki T; Yoshizumi F; Hiroshige S; Okamoto M; Fukuzawa K; Motohiro A; Maehara Y
In Vivo; 2018; 32(3):659-662. PubMed ID: 29695575
[TBL] [Abstract][Full Text] [Related]
37. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS
World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis of the efficacy and safety of iodine [
Fan W; Wu Y; Lu M; Yao W; Cui W; Zhao Y; Wang Y; Li J
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):451-459. PubMed ID: 30348520
[TBL] [Abstract][Full Text] [Related]
39. Emergency embolization in the treatment of ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization.
Sun JH; Wang LG; Bao HW; Lou JL; Cai LX; Wu C; Chen LM; Zheng SS
Hepatogastroenterology; 2010; 57(99-100):616-9. PubMed ID: 20698237
[TBL] [Abstract][Full Text] [Related]
40. Management of ruptured liver segment IV hepatocellular carcinoma: is transarterial embolization (TAE) superior to chemoembolization (TACE)?-the jury is still out.
Bakopoulos A; Koliakos N; Tsilimigras DI; Schizas D; Moris D; Angelopoulos A; Spanakos S; Spartalis E; Patapis P; Skandalakis P; Troupis T
Ann Transl Med; 2018 Jul; 6(13):272. PubMed ID: 30094258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
